Purchases and Sales Made in Q1 2025 in Aurinia Pharmaceuticals Inc. (AUPH)
This table provides information about the institutional ownership of Aurinia Pharmaceuticals Inc. (AUPH) during Q1 2025. The information is specifically focused on institutions that hold shares of Aurinia Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-66.9K- 2.29% |
$505K - $586K
|
2.85M
$23.9M
|
|
|
May 14, 2025
Q1 2025
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-100K- 38.12% |
$758K - $881K
|
163K
$1.37M
|
|
|
May 09, 2025
Q1 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-121K- 6.89% |
$911K - $1.06M
|
1.63M
$13.7M
|
|
|
May 09, 2025
Q1 2025
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-144K- 21.6% |
$1.08M - $1.26M
|
521K
$4.37M
|
|
|
May 02, 2025
Q1 2025
|
Segall Bryant & Hamill, LLC
Chicago, IL |
SELL
|
- |
-148K- 28.65% |
$1.12M - $1.3M
|
369K
$3.09M
|
|
|
May 19, 2025
Q1 2025
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-205K- 56.24% |
$1.54M - $1.79M
|
159K
$1.34M
|
|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-226K- 24.35% |
$1.7M - $1.98M
|
702K
$5.89M
|
|
|
May 15, 2025
Q1 2025
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-349K- 41.09% |
$2.64M - $3.06M
|
500K
$4.2M
|
|
|
May 12, 2025
Q1 2025
|
Citigroup Inc
|
SELL
|
- |
-558K- 84.28% |
$4.22M - $4.9M
|
104K
$874K
|
|
|
May 15, 2025
Q1 2025
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-1.4M- 21.88% |
$10.6M - $12.3M
|
5M
$42M
|